These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 32364441)

  • 21. Decreased Mortality of COVID-19 With Renin-Angiotensin-Aldosterone System Inhibitors Therapy in Patients With Hypertension: A Meta-Analysis.
    Guo X; Zhu Y; Hong Y
    Hypertension; 2020 Aug; 76(2):e13-e14. PubMed ID: 32458694
    [No Abstract]   [Full Text] [Related]  

  • 22. Reply to the letter of Mahajan and Gaur in response to the article: Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers (Singh et al.).
    Singh AK; Gupta R; Misra A
    Diabetes Metab Syndr; 2020; 14(5):729. PubMed ID: 32473904
    [No Abstract]   [Full Text] [Related]  

  • 23. Letter to the Editor - Circulating plasma levels of angiotensin II and aldosterone in patients with coronavirus disease 2019 (COVID-19): A preliminary report.
    Henry BM; Benoit S; Lippi G; Benoit J
    Prog Cardiovasc Dis; 2020; 63(5):702-703. PubMed ID: 32659343
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparative Impacts of ACE (Angiotensin-Converting Enzyme) Inhibitors Versus Angiotensin II Receptor Blockers on the Risk of COVID-19 Mortality.
    Zhou F; Liu YM; Xie J; Li H; Lei F; Yang H; Qin JJ; Cai J; Zhang XJ; Wu B; Xia M; Xiang D; Yang C; Ma X; Xu Q; Lu Z; Lu H; Xia X; Wang D; Liao X; Peng G; Yang J; Huang X; Zhang BH; Yuan Y; Wei X; Liu PP; Wang Y; Zhang P; She ZG; Xia J; Li H
    Hypertension; 2020 Aug; 76(2):e15-e17. PubMed ID: 32493070
    [No Abstract]   [Full Text] [Related]  

  • 25. Controversial Relationship Between Renin-Angiotensin System Inhibitors and Severity of COVID-19: Announcing a Large Multicentre Case-Control Study in Italy.
    Di Castelnuovo A; De Caterina R; de Gaetano G; Iacoviello L
    Hypertension; 2020 Aug; 76(2):312-313. PubMed ID: 32383624
    [No Abstract]   [Full Text] [Related]  

  • 26. 5 classes of antihypertensive drugs were not linked to positive COVID-19 test results or severe COVID-19.
    Fekete T
    Ann Intern Med; 2020 Sep; 173(6):JC35. PubMed ID: 32926815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. COVID-19 Interference with Renin-Angiotensin System in the Context of Heart Failure.
    Siniorakis E; Arvanitakis S; Nikolopoulos I; Elkouris M
    mBio; 2020 May; 11(3):. PubMed ID: 32444383
    [No Abstract]   [Full Text] [Related]  

  • 28. Possible Protective Effect of Renin-Angiotensin System Inhibitors in COVID-19 Induced Acute Kidney Injury.
    Kow CS; Hasan SS
    J Am Soc Nephrol; 2020 Aug; 31(8):1917-1918. PubMed ID: 32639940
    [No Abstract]   [Full Text] [Related]  

  • 29. [2019 Novel coronavirus, renin-angiotension system imbalance and coronavirus disease 2019].
    Fang Y; Guo Z; Chai Y; Zhang H; Wang Z
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 May; 32(5):613-617. PubMed ID: 32576357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Obesity and COVID-19.
    Azzolino D; Cesari M
    Front Endocrinol (Lausanne); 2020; 11():581356. PubMed ID: 33101213
    [No Abstract]   [Full Text] [Related]  

  • 31. COVID-19: The heart of the issue.
    Woodward B; Kermali M
    J Card Surg; 2020 Aug; 35(8):2112. PubMed ID: 32542802
    [No Abstract]   [Full Text] [Related]  

  • 32. SARS-CoV-2 Pathogenesis: Imbalance in the Renin-Angiotensin System Favors Lung Fibrosis.
    Delpino MV; Quarleri J
    Front Cell Infect Microbiol; 2020; 10():340. PubMed ID: 32596170
    [No Abstract]   [Full Text] [Related]  

  • 33. Managing long covid: don't overlook olfactory dysfunction.
    Hopkins C; Burges Watson DL; Kelly C; Leary V; Smith BC
    BMJ; 2020 Sep; 370():m3736. PubMed ID: 32978178
    [No Abstract]   [Full Text] [Related]  

  • 34. Central involvement of SARS-CoV-2 may aggravate ARDS and hypertension.
    Cure E; Cumhur Cure M; Vatansev H
    J Renin Angiotensin Aldosterone Syst; 2020; 21(4):1470320320972015. PubMed ID: 33169637
    [No Abstract]   [Full Text] [Related]  

  • 35. Long COVID: don't consign ME/CFS to history.
    White P
    Nature; 2020 Nov; 587(7833):197. PubMed ID: 33173222
    [No Abstract]   [Full Text] [Related]  

  • 36. COVID-19 and the pulmonary vascular injury.
    Dai HL; Guang XF
    J Renin Angiotensin Aldosterone Syst; 2020; 21(4):1470320320972276. PubMed ID: 33176538
    [No Abstract]   [Full Text] [Related]  

  • 37. Association between angiotensin blockade and COVID-19 severity in Hong Kong.
    Cheung KS; Hung IFN; Leung WK
    CMAJ; 2020 Jun; 192(23):E635. PubMed ID: 32575056
    [No Abstract]   [Full Text] [Related]  

  • 38. COVID-19 and RAAS blockers: Could Aliskiren be an appropriate option?
    Şen S; Üresin AY
    Turk Kardiyol Dern Ars; 2020 Oct; 48(7):631-634. PubMed ID: 33034579
    [No Abstract]   [Full Text] [Related]  

  • 39. Rights Don't Stand Alone: Responsibility for Rights in a Pandemic.
    Matose T; Lanphier E
    Am J Bioeth; 2020 Jul; 20(7):169-172. PubMed ID: 32716789
    [No Abstract]   [Full Text] [Related]  

  • 40. Obstructive sleep apnea, renin-angiotensin system, and COVID-19: possible interactions.
    Ekiz T; İnönü Köseoğlu H; Pazarlı AC
    J Clin Sleep Med; 2020 Aug; 16(8):1403-1404. PubMed ID: 32807298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.